Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor

समान संसाधन

• Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second‐line treatment for non–small‐cell lung cancer wild‐type or unknown status for EGFR
  द्वारा: Créquit, Perrine, और अन्य
  प्रकाशित: (2018)
• Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis
  द्वारा: Créquit, Perrine, और अन्य
  प्रकाशित: (2017)
• Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer
  द्वारा: Créquit, Perrine, और अन्य
  प्रकाशित: (2016)
• Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
  द्वारा: Bafeta, Aïda, और अन्य
  प्रकाशित: (2012)
• Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials
  द्वारा: Trinquart, Ludovic, और अन्य
  प्रकाशित: (2012)